Treatment After CDK4/6 Inhibitors

Breastcancer.org Podcast · Dec 6, 2023 · 7m

CDK4/6 inhibitors are used to treat both early-stage and advanced-stage hormone receptor-positive, HER2-negative breast cancer.

The CDK4/6 inhibitors are:

Ibrance (chemical name: palbociclib)

Kisqali (chemical name: ribociclib)

Verzenio (chemical name: abemaciclib)

At the 2023 San Antonio Breast Cancer Symposium, Dr. Stephanie Graff moderated an educational session to help people and their doctors decide on treatments after a CDK4/6 inhibitor has stopped working.

Listen to the podcast to hear Dr. Graff explain:

how the oral SERD, Orserdu (chemical name: elacestrant), might be used

how PARP…